Immune to Cancer: The CRI Blog
-
Meet the 2026 STARs: Julie Deutsch, MD
The future — it’s no longer about whether a therapy worked in aggregate. It’s now about whether… -
Before Cancer Takes Hold: The Science of Cancer Interception
Cancer does not begin on the day it is diagnosed. Long before a tumor appears on a… -
It Takes a Village to Carry Cancer
Everybody thinks about the actual cancer patient. They don’t always think about the number of people who… -
A New Milestone for Cancer Vaccines — Decades in the Making
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a patient’s immune… -
Can Viruses Fight Cancer? What Tudriqev Means for Patients With Melanoma
The U.S. Food and Drug Administration’s (FDA) accelerated approval of Tudriqev marks FDA’s first new approval of… -
Meet the 2026 STARs: Aaron Whiteley, PhD
I’m a microbiologist who’s passionate about immune signaling. Meet Aaron Whiteley, PhD, an Assistant Professor in the… -
The Future Starts Here: Meet the 2025–2026 Postdoctoral Fellows
Tomorrow’s breakthroughs in cancer immunotherapy begin with today’s early-career scientists. By investing in promising researchers at the… -
Why Is Lung Cancer Rising in Nonsmokers?
For decades, lung cancer has been closely associated with smoking — and for good reason. Smoking remains… -
From Bold Ideas to Breakthroughs: Introducing CRI’s 2026 CLIP & Technology Impact Award Projects
What if the next advance in cancer immunotherapy starts with one bold idea? Every breakthrough begins with…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.